The effect of prolonged natalizumab treatment on anxiety and safety in JC virus-seropositive MS patients; a follow-up study

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1668-1669
JournalMultiple Sclerosis
Volume20
Issue number12
DOIs
Publication statusPublished - 2014

Cite this

@article{a61886d87c22443386c296211b87d792,
title = "The effect of prolonged natalizumab treatment on anxiety and safety in JC virus-seropositive MS patients; a follow-up study",
author = "{van Rossum}, J.A. and A. Vennegoor and J. Killestein",
year = "2014",
doi = "10.1177/1352458514543341",
language = "Undefined/Unknown",
volume = "20",
pages = "1668--1669",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "12",

}

The effect of prolonged natalizumab treatment on anxiety and safety in JC virus-seropositive MS patients; a follow-up study. / van Rossum, J.A.; Vennegoor, A.; Killestein, J.

In: Multiple Sclerosis, Vol. 20, No. 12, 2014, p. 1668-1669.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - The effect of prolonged natalizumab treatment on anxiety and safety in JC virus-seropositive MS patients; a follow-up study

AU - van Rossum, J.A.

AU - Vennegoor, A.

AU - Killestein, J.

PY - 2014

Y1 - 2014

U2 - 10.1177/1352458514543341

DO - 10.1177/1352458514543341

M3 - Article

VL - 20

SP - 1668

EP - 1669

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 12

ER -